Life Sciences Genexine Appoints Industry Veteran Neil Warma as Chief Executive Officer to Accelerate Global… AIT News Desk May 25, 2022 - Genexine to focus on global drug development and commercialization - Near term milestones should drive shareholder value - Renewed effort to…
Life Sciences Rheos Medicines Announces Publication of New Data to Support Targeting MALT1 to Treat Autoimmune and… AIT News Desk May 9, 2022 – Preclinical data demonstrate effects of MALT1 inhibition on suppression of pro-inflammatory cell activation, attenuation of multiple…
Machine Learning AbbVie Chooses Cerebras Systems to Accelerate AI Biopharmaceutical Research AIT News Desk May 9, 2022 Cerebras CS-2 accelerates artificial intelligence work while radically reducing power consumption Cerebras Systems, the pioneer in high…
Life Sciences Alvotech Improves Access to Capital and Streamlines Path to Expected Public Listing on NASDAQ Stock… AIT News Desk Apr 20, 2022 Alvotech and Oaktree Acquisition Corp. II establish financing facilities to enhance the company’s capital position and to replace any redeemed…
Life Sciences Asahi Kasei Medical to Acquire Bionova Scientific, U.S.-based Biopharmaceutical CDMO AIT News Desk Apr 19, 2022 Asahi Kasei Medical concluded an agreement on April 14, 2022 (JST) through a U.S. subsidiary to wholly acquire Bionova Scientific, LLC, a provider of…
Life Sciences LENZ Therapeutics and JIXING Announce an Exclusive Greater China License Agreement; RTW to Invest in… AIT News Desk Apr 18, 2022 – JIXING to lead development and commercialization of LNZ100 and LNZ101 in Greater China – – LENZ to receive up to $110 million in upfront and…
Life Sciences Blade Therapeutics Announces Feedback from FDA on End-of-Phase 1 Data Package AIT News Desk Apr 4, 2022 U.S. Food and Drug Administration (FDA) provides feedback necessary to proceed into a phase 2 proof of concept (PoC)/dose ranging study of…
Machine Learning Absci Develops Groundbreaking Machine Learning Models for In-Silico Antibody Design, Powered by… AIT News Desk Mar 28, 2022 Absci to present in-silico drug discovery technology at NVIDIA GTC Breakthrough ML achievements highlight the viability of the computational lead…
Technology Avacta Appoints Dr Christina Coughlin as Non-Executive Director AIT News Desk Mar 22, 2022 Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its…
Machine Learning NexImmune and Zephyr AI Announce a Strategic Partnership in Oncology for Target Discovery and… AIT News Desk Mar 21, 2022 NexImmune, Inc. and Zephyr AI (Zephyr) announced a strategic partnership focusing on the discovery and validation of novel targets for new…